Michael F Minnick

Dr. Michael F Minnick

orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
NPNermi L. Parrow
Nermi L. Parrow
RFRobert E. Fleming
Robert E. Fleming
MMMichael F Minnick
Michael F Minnick
The proliferative capability of many invasive pathogens is limited by the bioavailability of iron. Pathogens have thus developed strategies to obtain iron from their host organisms. In turn, host defense strategies have evolved to sequester iron from invasive pathogens. This review explores the mechanisms employed by bacterial pathogens to gain access to host iron sources, the role of iron in bacterial virulence, and iron-related genes required for the establishment or maintenance of infection. Host defenses to limit iron availability for bacterial growth during the acute-phase response and the consequences of iron overload conditions on susceptibility to bacterial infection are also examined. The evidence summarized herein demonstrates the importance of iron bioavailability in influencing the risk of infection and the ability of the host to clear the pathogen.

17 July 2014 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
MMMichael F Minnick
Michael F Minnick
BABurt E. Anderson
Burt E. Anderson
ALAmorce Lima
Amorce Lima
JBJames M. Battisti
James M. Battisti
PLPhillip G. Lawyer
Phillip G. Lawyer
RBRichard Birtles
Richard Birtles
Bartonella bacilliformis is the bacterial agent of Carrión's disease and is presumed to be transmitted between humans by phlebotomine sand flies. Carrión's disease is endemic to high-altitude valleys of the South American Andes, and the first reported outbreak (1871) resulted in over 4,000 casualties. Since then, numerous outbreaks have been documented in endemic regions, and over the last two decades, outbreaks have occurred at atypical elevations, strongly suggesting that the area of endemicity is expanding. Approximately 1.7 million South Americans are estimated to be at risk in an area covering roughly 145,000 km2 of Ecuador, Colombia, and Peru. Although disease manifestations vary, two disparate syndromes can occur independently or sequentially. The first, Oroya fever, occurs approximately 60 days following the bite of an infected sand fly, in which infection of nearly all erythrocytes results in an acute hemolytic anemia with attendant symptoms of fever, jaundice, and myalgia. This phase of Carrión's disease often includes secondary infections and is fatal in up to 88% of patients without antimicrobial intervention. The second syndrome, referred to as verruga peruana, describes the endothelialcell-derived, blood-filled tumors that develop on the surface of the skin. Verrugae are rarely fatal, but can bleed and scar the patient. Moreover, these persistently infected humans provide a reservoir for infecting sand flies and thus maintaining B. bacilliformis in nature. Here, we discuss the current state of knowledge regarding this life-threatening, neglected bacterial pathogen and review its host-cell parasitism, molecular pathogenesis, phylogeny, sand fly vectors, diagnostics, and prospects for control.

24 March 1999 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
JCJared L. Cartwright
Jared L. Cartwright
PBPhillipa Britton
Phillipa Britton
MMMichael F Minnick
Michael F Minnick
AMAlexander G. McLennan
Alexander G. McLennan

6 August 2009 in Future Microbiology
Verified
Journal Article
Closed access
MMMichael F Minnick
Michael F Minnick
JBJames M Battisti
James M Battisti
It has been nearly two decades since the discovery of Bartonella as an agent of bacillary angiomatosis in AIDS patients and persistent bacteremia and ‘nonculturable’ endocarditis in homeless people. Since that time, the number of Bartonella species identified has increased from one to 24, and 10 of these bacteria are associated with human disease. Although Bartonella is the only genus that infects human erythrocytes and triggers pathological angiogenesis in the vascular bed, the group remains understudied compared with most other bacterial pathogens. Numerous questions regarding Bartonella’s molecular pathogenesis and epidemiology remain unanswered. Virtually every mammal harbors one or more Bartonella species and their transmission typically involves a hematophagous arthropod vector. However, many details regarding epidemiology and the public health threat imposed by these animal reservoirs is unclear. A handful of studies have shown that bartonellae are highly-adapted pathogens whose parasitic strategy ...

1 July 2001 in Infection and Immunity
Verified
Journal Article
Closed access
SCSherry A. Coleman
Sherry A. Coleman
MMMichael F Minnick
Michael F Minnick
DBD. L. Burns
D. L. Burns
The invasion-associated locus A and B genes (ialAB) ofBartonella bacilliformis were previously shown to confer an erythrocyte-invasive phenotype upon Escherichia coli, indirectly implicating their role in virulence. We report the first direct demonstration of a role for ialB as a virulence factor in B. bacilliformis. The presence of a secretory signal sequence and amino acid sequence similarity to two known outer membrane proteins involved in virulence suggested that IalB was an outer membrane protein. To develop an antiserum for protein localization, the ialB gene was cloned in frame into an expression vector with a six-histidine tag and under control of thelacZ promoter. The IalB fusion protein was purified by nickel affinity chromatography and used to raise polyclonal antibodies. IalB was initially localized to the bacterial membrane fraction. To further localize IalB, B. bacilliformis inner and outer membranes were fractionated by sucrose density gradient centrifugation and identified by appearance, buoyant density (ρ), and cytochromeb content. Inner and outer membrane proteins were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and IalB was positively identified by Western blot. Contrary to expectations, IalB was localized to the inner membrane of the pathogen. To directly demonstrate a role for IalB in erythrocyte parasitism, the B. bacilliformis ialB gene was disrupted by insertional mutagenesis. The resulting ialB mutant strain was complemented in trans with a replicative plasmid encoding the full-length ialB gene. PCR and high-stringency DNA hybridization confirmed mutagenesis and transcomplementation events. Abrogation and restoration of ialB expression was verified by SDS-PAGE and immunoblotting. In vitro virulence assays showed that mutagenesis of ialB decreased bacterial association and invasion of human erythrocytes by 47 to 53% relative to controls. Transcomplementation of ialB restored erythrocyte association and invasion rates to levels observed in the parental strain. These data provide direct evidence for IalB's role in erythrocyte parasitism and represent the first demonstration of molecular Koch's postulates for a Bartonella species. Bartonella bacilliformisis the only bacterium known to invade human erythrocytes. The pathogen is the causative agent of the human disease, Oroya fever, a biphasic illness whose primary-phase symptoms include a severe hemolytic anemia, where up to 100% of the circulating erythrocytes can be parasitized and 80% lysed (1, 15, 31). If untreated, this phase of the disease has a 40% fatality rate (44). Treatment with penicillin, tetracycline, or aminoglycosides is effective (43), but diagnosis can be difficult due to the slow growth and fastidious nature of the bacterium. The secondary phase of Oroya fever occurs 4 to 8 weeks following the primary hemolytic phase and is characterized by hemangiomas, nicknamed verruga peruana, on the patient's head, neck, and extremities. During the secondary phase, bacterial colonization and invasion shifts from erythrocytes to vascular endothelial cells (13, 14, 21) and results in neovascularization (13). This phase of the disease is rarely fatal but can last up to several months (43) and may cause permanent disfigurement. B. bacilliformis is transmitted by the phlebotamine sandfly, Lutzomyia verrucarum. Historically, Oroya fever has been limited to the mountainous regions of South America, presumably due to geographical restriction of its vector (19). However, recent reports of Oroya fever in coastal areas of South America suggest that the range of this pathogen is expanding (1). Although other bacteria are known to parasitize mammalian erythrocytes (e.g., Anaplasma and Haemobartonella species),B. bacilliformis is unsurpassed among bacteria in its efficiency as an erythrocyte parasite. B. bacilliformis is able to invade nearly all circulating erythrocytes during the acute phase of infection. Erythrocytes lack the actin cytoskeleton necessary for bacterial uptake by induced endocytosis, although endocytosis can be induced under experimental conditions (35, 40). Treatment of erythrocytes with glycolysis and proton-motive-force inhibitors has no effect on Bartonella adhesion, suggesting that these host cells play a passive role in invasion (42). In contrast, B. bacilliformis plays an active role during erythrocyte invasion requiring both respiration and proton motive force (42). Taken together, these data indicate that B. bacilliformis is the only active participant in erythrocyte adherence and invasion. In contrast,B. bacilliformis entry into endothelial and epithelial cells differs significantly from its invasion of erythrocytes. Bacterium-induced rearrangement of the endothelial and epithelial cell cytoskeleton during endocytosis enhances bacterial uptake, while cytochalasin D treatment, inhibiting actin filament formation, reduces internalization by ∼30% (21). The B. bacilliformis invasion-associated locus A and B genes (ialAB) were indirectly shown to be involved in erythrocyte invasion by conferring an erythrocyte-invasive phenotype upon minimally invasive Escherichia coli strains (27). IalA has since been characterized as a (di)nucleoside polyphosphate hydrolase thought to be involved in reducing levels of stress-induced dinucleotides during invasion, thus aiding bacterial survival (9, 11). IalB was shown to contain a putative 22-amino-acid secretory signal sequence and to have approximately 60% amino acid similarity to the virulence determinants Ail of Yersinia enterocolitica and Rck of Salmonella enterica serovar Typhimurium. The presence of a potential secretory sequence and similarity of IalB to two outer membrane virulence determinants led to our hypothesis that IalB is exported to the bacterial surface, where it functions as an invasion factor. This study was undertaken to localize the IalB protein and directly determine its role in human...

1 December 2000 in Infection and Immunity
Verified
Journal Article
Closed access
PDF file
JCJames A. Carroll
James A. Carroll
SCSherry A. Coleman
Sherry A. Coleman
LSLaura S. Smitherman
Laura S. Smitherman
MMMichael F Minnick
Michael F Minnick
Bartonella quintana , the agent of trench fever and a cause of endocarditis and bacillary angiomatosis in humans, has the highest reported in vitro hemin requirement for any bacterium. We determined that eight membrane-associated proteins from B. quintana bind hemin and that a ∼25-kDa protein (HbpA) was the dominant hemin-binding protein. Like many outer membrane proteins, HbpA partitions to the detergent phase of a Triton X-114 extract of the cell and is heat modifiable, displaying an apparent molecular mass shift from approximately 25 to 30 kDa when solubilized at 100°C. Immunoblots of purified outer and inner membranes and immunoelectron microscopy with whole cells show that HbpA is strictly located in the outer membrane and surface exposed, respectively. The N-terminal sequence of mature HbpA was determined and used to clone the HbpA-encoding gene ( hbpA ) from a lambda genomic library. The hbpA gene is 816 bp in length, encoding a predicted immature protein of approximately 29.3 kDa and a mature protein of 27.1 kDa. A Fur box homolog with 53% identity to the Escherichia coli Fur consensus is located upstream of hbpA and may be involved in regulating expression. BLAST searches indicate that the closest homologs to HbpA include the Bartonella henselae phage-associated membrane protein, Pap31 (58.4% identity), and the OMP31 porin from Brucella melitensis (31.7% identity). High-stringency Southern blots indicate that all five pathogenic Bartonella spp. possess hbpA homologs. Recombinant HbpA can bind hemin in vitro; however, it does not confer a hemin-binding phenotype upon E. coli . Intact B. quintana treated with purified anti-HbpA Fab fragments show a significant ( P < 0.004) dose-dependent decrease in hemin binding relative to controls, suggesting that HbpA plays an active role in hemin acquisition and therefore pathogenesis. HbpA is the first potential virulence determinant characterized from B. quintana .